MEDDIC scorecard

Sales tools

Qualify complex B2B deals on Metrics, Economic Buyer, Decision Criteria, Decision Process, Pain, and Champion.

MEDDIC is a rigorous framework for high-value B2B sales. It scores six dimensions and puts particular weight on reaching the Economic Buyer and building a Champion who sells internally on your behalf.

Where MEDDIC came from

MEDDIC was born in the mid-1990s inside PTC (Parametric Technology Corporation), where a global sales leadership team set out to codify why some enterprise deals closed and others stalled. The framework is most commonly credited to Dick Dunkel and Jack Napoli, who worked alongside sales leader John McMahon, and it distilled the habits of PTC's top performers into six repeatable elements. The impact was dramatic: PTC grew revenue from roughly 300 million dollars to 1 billion dollars in about four years, and MEDDIC became the qualification discipline behind that run. Because it emerged from real deal reviews rather than theory, MEDDIC is a qualification checklist that reflects what actually moved complex sales forward.

MEDDIC emerged because enterprise B2B selling had become too complex for gut feel: large deals involve many stakeholders, formal buying processes, and budgets controlled by executives the seller rarely meets early. As PTC alumni moved on to other technology companies, they carried the framework with them, and it spread through the enterprise software world as a shared vocabulary for deal qualification. Later it was formalized and taught more widely, including through MEDDIC Academy, founded by Darius Lahoutifard. Over time the acronym gained extensions: MEDDICC adds a second C for Competition, and MEDDPICC adds a P for the Paper Process (contracting and procurement).

What each part of MEDDIC means

  • Metrics: The quantified economic impact your solution delivers, such as revenue gained or cost and time saved. Common mistake: settling for vague benefits instead of numbers the buyer will actually stand behind.
  • Economic Buyer: The single person with the ultimate authority to release the budget. Common mistake: mistaking an influential contact for the economic buyer and never getting into the room with the real one.
  • Decision Criteria: The formal and informal standards the buyer will use to choose a vendor. Common mistake: guessing the criteria rather than uncovering and shaping them, then losing on a requirement you never knew mattered.
  • Decision Process: The concrete steps, approvals, and timeline the buyer follows to reach a signed deal. Common mistake: tracking your own sales stages while staying blind to the buyer's internal process.
  • Identify Pain: The specific business pain that is costly enough to justify action now. Common mistake: pitching features against a "nice to have" problem that never survives budget prioritization.
  • Champion: An influential internal advocate with a personal stake in your win who sells for you when you are not in the room. Common mistake: relying on a friendly coach who likes you but has no power to move the deal.

When to use MEDDIC (and when not to)

MEDDIC shines in high-value, multi-stakeholder enterprise deals where a wrong qualification call is expensive and forecasting accuracy matters. It is deliberately heavy, so it pays off when the deal complexity justifies the discovery effort, and it is overkill when a lightweight qualifier like BANT would do.

  • Best fit: large enterprise or complex B2B opportunities with several stakeholders, a formal buying process, and long sales cycles.
  • Best fit: teams that need disciplined, defensible forecasts and consistent deal reviews across many reps.
  • Overkill: small, fast, transactional deals with a single decision maker, where the framework adds friction without improving win rates.

Strengths of MEDDIC

  • Forces sellers to confirm real budget authority and quantified value, which sharpens forecast accuracy and reduces late-stage surprises.
  • Surfaces gaps early: a missing economic buyer or champion becomes visible before you invest weeks in a doomed deal.
  • Gives managers a shared vocabulary for deal reviews, so coaching and pipeline conversations stay consistent across the team.
  • Centers the buyer's pain, criteria, and process, keeping discovery focused on what actually drives the purchase decision.
  • Scales as complexity grows through its MEDDICC and MEDDPICC extensions without discarding what reps already learned.

Limitations of MEDDIC

  • It is a qualification framework, not a full sales process: it tells you whether a deal is real, not step by step how to run the sale.
  • Applying it well takes discipline and CRM rigor, and reps often let the fields decay within months of training without ongoing reinforcement.
  • Turned into a rote checklist, it becomes box-ticking interrogation that damages rapport instead of guiding a real conversation.
  • It is heavy for small or transactional deals, where the discovery overhead outweighs the benefit.
  • It leans on strong discovery skill, so weak questioning produces confident-looking but shallow qualification.

How to score a deal with this MEDDIC scorecard

FactorWhat it checks
MetricsHave you quantified the economic impact (metrics) of solving this?No
Economic BuyerHave you identified and accessed the person who controls the budget?Yes
Decision CriteriaDo you know the criteria they'll use to choose a vendor?No
Decision ProcessDo you understand the steps and approvals to a signed deal?No
Identify PainHave you identified a pain significant enough to drive action?No
ChampionDo you have an internal advocate who sells on your behalf?No
  1. Rate each factor from 0 (unknown or none) to 3 (strong or confirmed).
  2. The tool computes a weighted score out of 100 as you go.
  3. Read the verdict: Qualified (67% and up), Nurture (34% and up), or Disqualify (below 34%).
  4. Work the weakest factors first. Each gap comes with the question to ask on your next call.
  5. Copy the summary into your CRM, or share the link with your manager for a second opinion.

When a deal cannot be Qualified

If one of them scores 0, for example no budget or no access to a decision-maker, the verdict is capped at Nurture no matter how high the total is. That keeps a shiny score from hiding a deal-breaker.

Automate MEDDIC scoring, or compare it with the other qualification frameworks in this family:

Sources

Operated by

Turnint AI
unbounded pioneering inc

Turnint AI Tools is a suite of free tools built and operated by unbounded pioneering inc, the company behind the Turnint AI agent platform.

Ryosuke Suzuki
Ryosuke SuzukiFounder & CEO

Founder & CEO of Unbounded Pioneering Inc., the company behind the Turnint AI agent platform, and an expert in machine learning and AI product development. He began his career in machine learning research at a university laboratory, then designed and built large-scale products as a software engineer at PLAID, Rakuten, and Recruit, while also driving new business development. Now specializing in generative AI and AI agents, he works across both engineering and business development, and is a named inventor on multiple granted patents in web technology.

Named inventor on granted patents JP6887648 & JP7480958 · Patent pending on Turnint AI technology

Get in touch

Thanks for reaching out

Thank you for your interest in our company. A member of our team will get back to you within one business day.

What we can help with

  • Adopting and getting the most out of Turnint AI
  • A demo or trial of Turnint AI
  • AI adoption in general (beyond our own product, too)
  • Alliances and partnerships
  • Any other questions

Talk to us online

You can also book a meeting directly from the calendar.

Pick a template or write your own message.